关注
Cervantes A
Cervantes A
Professor of Medicine. University of Valencia
在 uv.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont, A Figer, M Seymour, M Homerin, A Hmissi, J Cassidy, ...
Journal of Clinical Oncology 18 (16), 2938-2947, 2000
50902000
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
34682016
A phase 3 trial of bevacizumab in ovarian cancer
TJ Perren, AM Swart, J Pfisterer, JA Ledermann, E Pujade-Lauraine, ...
New England Journal of Medicine 365 (26), 2484-2496, 2011
25712011
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 30 (8), 1194-1220, 2019
24192019
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making
HJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ...
Annals of oncology 23 (10), 2479-2516, 2012
18632012
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R Glynne-Jones, L Wyrwicz, E Tiret, G Brown, C Rödel, A Cervantes, ...
Annals of Oncology 28, iv22-iv40, 2017
18052017
Capecitabine as adjuvant treatment for stage III colon cancer
C Twelves, A Wong, MP Nowacki, M Abt, H Burris III, A Carrato, J Cassidy, ...
New England Journal of Medicine 352 (26), 2696-2704, 2005
16952005
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
EC Smyth, M Verheij, W Allum, D Cunningham, A Cervantes, D Arnold
Annals of oncology 27, v38-v49, 2016
16922016
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Van Cutsem, A Cervantes, B Nordlinger, D Arnold
Annals of oncology 25, iii1-iii9, 2014
13872014
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R Labianca, B Nordlinger, GD Beretta, S Mosconi, M Mandalà, ...
Annals of oncology 24, vi64-vi72, 2013
11032013
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer—a GERCOR study
C Tournigand, A Cervantes, A Figer, G Lledo, M Flesch, M Buyse, ...
Journal of clinical oncology 24 (3), 394-400, 2006
10812006
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in …
RR Bahadoer, EA Dijkstra, B van Etten, CAM Marijnen, H Putter, ...
The Lancet Oncology 22 (1), 29-42, 2021
10452021
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
AM Oza, AD Cook, J Pfisterer, A Embleton, JA Ledermann, ...
The Lancet Oncology 16 (8), 928-936, 2015
9102015
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ...
Annals of Oncology 29, iv238-iv255, 2018
8942018
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six …
D Arnold, B Lueza, JY Douillard, M Peeters, HJ Lenz, A Venook, ...
Annals of oncology 28 (8), 1713-1729, 2017
8862017
First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
J Tabernero, GI Shapiro, PM LoRusso, A Cervantes, GK Schwartz, ...
Cancer discovery 3 (4), 406-417, 2013
7752013
Integration of oncology and palliative care: a Lancet Oncology Commission
S Kaasa, JH Loge, M Aapro, T Albreht, R Anderson, E Bruera, C Brunelli, ...
The lancet oncology 19 (11), e588-e653, 2018
6832018
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Glimelius, E Tiret, A Cervantes, D Arnold
Annals of oncology 24, vi81-vi88, 2013
6622013
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)
GJS Rustin, I Vergote, E Eisenhauer, E Pujade-Lauraine, M Quinn, ...
International Journal of Gynecologic Cancer 21 (2), 2011
6322011
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E Van Cutsem, B Nordlinger, A Cervantes
Annals of oncology 21, v93-v97, 2010
6052010
系统目前无法执行此操作,请稍后再试。
文章 1–20